30 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Not
Disclose
Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
for the Option Exchange were determined using the Black-Scholes model and are based on, among other things, $0.679, the per share closing trading
SC TO-I
htb7okf8t3trjfoj02b
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
mfxt3 9n0
30 Jan 24
Issuer tender offer statement
7:04am
8-K
EX-4.2
nu58z5l h2z0zl0nvmq4
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
424B4
krhcge1 om06rv9em6xw
1 Jul 21
Prospectus supplement with pricing info
4:31pm